Results In 'The New England Journal Of Medicine' Confirm Novartis Drug Femara(R) Is S

[News]

Newly published data in The New England Journal of Medicine affirm five-year upfront use of Femara((R)) (letrozole tablets) following surgery as an optimal treatment approach versus tamoxifen for postmenopausal women with early stage breast cancer (hormone-receptor positive).

More... (http://www.medicalnewstoday.com/articles/161230.php)